Andrrea Zellner
Nurse Practitioner · Macon, GANPI 1770042228
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 32.9% of the total. Reporting peaked in 2022 at $1,284 and has fallen 97.7% since, to $30 in 2025.
Across 116 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$657
- Ardelyx, Inc.$209
- Vanda Pharmaceuticals Inc.$191
- Sunovion Pharmaceuticals Inc.$128
- Lilly USA, LLC$114
- AstraZeneca$65
- plus $635 from 22 others
What the payments were for
- Food & beverage$2,000100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $657 |
| Ardelyx, Inc. | 8 | $209 |
| Vanda Pharmaceuticals Inc. | 13 | $191 |
| Sunovion Pharmaceuticals Inc. | 6 | $128 |
| Lilly USA, LLC | 8 | $114 |
| AstraZeneca | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| GSK | 3 | $51 |
| Boehringer Ingelheim | 2 | $46 |
| CMP Pharma, Inc. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Merck | 2 | $39 |
| Novo Nordisk | 2 | $36 |
| Grifols USA, LLC | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $26 |
| Bayer | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Pfizer | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Urovant Sciences Inc | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IBSRELA$135
How this compares
$2,000 in reported general payments places this provider in the 80th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Scopolamine | 16 | $959 |
| Metoprolol Tartrate | 12 | $77 |
| Metformin Hcl | 13 | $63 |
| Montelukast Sodium | 12 | $9 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Macon
- Jennifer StanfieldMacon$15K
- Amber WilsonMacon$12K
- Staci BennettMacon$12K
- Ashley VinsonMacon$11K
- Bobbie YoungMacon$9K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.